Glioma morphology and tumor-induced vascular alterations revealed in seven rodent glioma models by in vivo magnetic resonance imaging and angiography.
about
Markers of Response to Antiangiogenic Therapies in Colorectal Cancer: Where Are We Now and What Should Be Next?MR image-guided delivery of cisplatin-loaded brain-penetrating nanoparticles to invasive glioma with focused ultrasound.Non-invasive imaging for studying anti-angiogenic therapy effects.Investigating intracranial tumour growth patterns with multiparametric MRI incorporating Gd-DTPA and USPIO-enhanced imaging.Metabolic profiling of dividing cells in live rodent brain by proton magnetic resonance spectroscopy (1HMRS) and LCModel analysisMathematical Analysis of Glioma Growth in a Murine Model.Cyclic-RGDyC functionalized liposomes for dual-targeting of tumor vasculature and cancer cells in glioblastoma: An in vitro boron neutron capture therapy studyIn vivo characterization of several rodent glioma models by 1H MRSA new anti-glioma therapy, AG119: pre-clinical assessment in a mouse GL261 glioma model.Imaging of Orthotopic Glioblastoma Xenografts in Mice Using a Clinical CT Scanner: Comparison with Micro-CT and HistologyELTD1, a potential new biomarker for gliomas.Molecular MRI differentiation of VEGF receptor-2 levels in C6 and RG2 glioma modelsMultiscale imaging and computational modeling of blood flow in the tumor vasculature.MR Vascular Fingerprinting in Stroke and Brain Tumors Models.A mechanically coupled reaction-diffusion model that incorporates intra-tumoural heterogeneity to predict in vivo glioma growth.Evaluation of resveratrol sensitivities and metabolic patterns in human and rat glioblastoma cells.Tumor growth analysis by magnetic resonance imaging of the C6 glioblastoma model with prospects for the assessment of magnetohyperthermia therapy.Conversion of arterial input functions for dual pharmacokinetic modeling using Gd-DTPA/MRI and 18F-FDG/PET.Creatine CEST MRI for Differentiating Gliomas with Different Degrees of Aggressiveness.ELTD1, an effective anti-angiogenic target for gliomas: preclinical assessment in mouse GL261 and human G55 xenograft glioma models.Comparison of digital subtraction angiography, micro-computed tomography angiography and magnetic resonance angiography in the assessment of the cerebrovascular system in live mice.In vivo X-ray digital subtraction and CT angiography of the murine cerebrovasculature using an intra-arterial route of contrast injection.Clinical application value of 3.0T MR diffusion tensor imaging in grade diagnosis of gliomas.Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcome.AG488 as a therapy against gliomas.MRI assessment of experimental gliomas using 17.6 T.Three-dimensional susceptibility-weighted imaging at 7 T using fractal-based quantitative analysis to grade gliomas.Immune microenvironment of experimental rat C6 gliomas resembles human glioblastomas.Quantification of microvascular cerebral blood flux and late-stage tumor compartmentalization in 9L gliosarcoma using flow enhanced MRI.Correlations between perfusion MR imaging cerebral blood volume, microvessel quantification, and clinical outcome using stereotactic analysis in recurrent high-grade glioma.Function of neuronal nitric oxide synthase enzyme in temozolomide-induced damage of astrocytic tumor cells.
P2860
Q26752752-FDF35218-DD5C-4FE9-853F-C7F46322BD27Q30252977-B458C9F9-7EFA-466A-A8A5-14BB8ED43915Q30447988-BD332D8F-87CF-4721-AC68-19BB71EC72C9Q31133294-524C2B43-66DB-4004-95CC-04D3F6E7DBBDQ33599498-71A410DE-B8B0-4C92-81CC-5CB196ED17D9Q33747076-6DEAC538-D40E-4D22-954B-9C77419FE6E4Q33829590-855A54B7-BF06-4CCB-8B6B-D6E5C7992BBAQ34033507-910EFD03-1251-4751-80F3-730B8A749238Q35692849-648E14B6-0F05-4734-8D86-C749ECD7F73DQ36187408-31C9E690-E834-488C-9D64-3A67063C4E41Q36564447-3BB18E72-8935-4B78-97AB-7BDC936E31BDQ37025641-04A833D6-3149-4D2D-B390-7B50848297DFQ37259677-2D6A463A-3A0D-4D48-8B50-FAA2D0B622C3Q37435184-0E3E3231-109B-4D4D-AC66-87925E29197FQ38885308-3871366E-BC30-41D8-82FD-58F2B869FA18Q39103076-0D9BA781-FB1D-4B02-9AE0-D51185AB1935Q39263838-81EFFFBC-9CAC-4436-97CE-8DC892E9E066Q39351705-EDD325A1-ECD4-4FDC-8676-0309D936EC03Q39474060-FD213994-8F34-4EAA-BC47-D5AD8266DC87Q39601750-23E0D0AF-D6CB-4CCE-94EF-71B3F93BD511Q39683854-2DAA32ED-6416-4F6D-BD47-AE3C6FE5FECFQ40035107-E8CEF205-CF7F-45A8-A1B0-489F768E12E8Q41145194-614D0946-70A1-468A-AC46-E8E56E624709Q42379504-8D37F6A1-903B-4311-9EA9-0922CFAF5503Q42700872-53014E22-297C-4900-A394-5C644120E69CQ44178525-3DB46EF6-3F97-4EC2-BD5D-C2BE26C36D3BQ44486247-A5832C1F-9804-4E94-8F8E-E7A840552A66Q47135965-E9770770-427B-4F46-BF53-FD65BB49ACD0Q48201552-551418C0-FD57-4F1B-9362-AA6CC4F81180Q51495475-A462EA66-5A01-4F09-BD48-17F05B8910EFQ52649753-638EA894-4124-41E0-88D9-8766F26DF038
P2860
Glioma morphology and tumor-induced vascular alterations revealed in seven rodent glioma models by in vivo magnetic resonance imaging and angiography.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Glioma morphology and tumor-in ...... nance imaging and angiography.
@ast
Glioma morphology and tumor-in ...... nance imaging and angiography.
@en
Glioma morphology and tumor-in ...... nance imaging and angiography.
@nl
type
label
Glioma morphology and tumor-in ...... nance imaging and angiography.
@ast
Glioma morphology and tumor-in ...... nance imaging and angiography.
@en
Glioma morphology and tumor-in ...... nance imaging and angiography.
@nl
prefLabel
Glioma morphology and tumor-in ...... nance imaging and angiography.
@ast
Glioma morphology and tumor-in ...... nance imaging and angiography.
@en
Glioma morphology and tumor-in ...... nance imaging and angiography.
@nl
P2093
P2860
P356
P1476
Glioma morphology and tumor-in ...... nance imaging and angiography.
@en
P2093
Debbie Saunders
Jamie Pearson
Jessica Hoyle
Megan Lerner
Nataliya Smith
Rheal A Towner
Sabrina Doblas
P2860
P304
P356
10.1002/JMRI.22263
P577
2010-08-01T00:00:00Z